Biologics trend leads pharmaceuticals

The general stabilization in per-capita medical claims cost — what services cost the health plan before the member is charged — for the managed care industry has not, for the most part, spilled over to biologics, according to a survey by the Segal Co. The consulting company's ninth annual survey of health insurers, PBMs, and third-party administrators forecasts "continued declines in trends in 2006 for every coverage surveyed."

However, the company adds that, "the projected trend for biotechnology or specialty drugs is increasing at a rapid rate: 21.6 percent in 2006, approximately 8 percentage points above aggregate retail trend. The 2006 projection was obtained through a survey taken in summer 2005.

Burden of supplying pharmaceuticals, biologics

Note: No figures available for cost of biologics in 2004.

SOURCE: 2006 Segal Health Plan Cost Trend Survey.

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to or online at

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.


Managed Care
By Peter Wehrwein
Managed Care
By Howard Wolinsky